ClinConnect ClinConnect Logo
Search / Trial NCT02066337

Effect of Ozone Gel on Treatment of Chronic Periodontitis

Launched by OCTOBER 6 UNIVERSITY · Feb 14, 2014

Trial Information

Current as of May 14, 2025

Completed

Keywords

Ozone Gel Antioxidants Chronic Periodontitis Superoxide Dismutase

ClinConnect Summary

In this study, the investigators tested the effect of ozone gel as a local delivery system in treatment of chronic periodontitis in term of probing pocket depth reduction, mean gain in clinical attachment level, a more rise in BD values as well as greater reduction in SOD activity compared to scaling and root planing (SRP) alone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. The participant's age ranged between 30 and 60 years.
  • 2. All of the patients suffered from chronic periodontitis with attachment loss ≥ 5mm.
  • 3. Willingness to participate and sign the informed consent.
  • Exclusion Criteria:
  • 1. Any systemic disease that affect the periodontium.
  • 2. Pregnancy, lactation, postmenopausal women
  • 3. People who take anti-inflammatory drugs, antibiotics or vitamins within the previous 3 month.
  • 4. People who use mouth washes regularly
  • 5. Heavy smoking (\> 10 cigarettes/day)
  • 6. History of alcohol abuse.
  • 7. Participation in other clinical trials.

About October 6 University

October 6 University is a prestigious educational institution dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and excellence, the university fosters a collaborative environment that integrates cutting-edge scientific research with practical clinical applications. Its commitment to improving healthcare outcomes is reflected in its comprehensive approach to clinical trials, where it engages in rigorous methodologies and ethical standards to ensure the safety and efficacy of new treatments. Through its dedicated research facilities and highly qualified personnel, October 6 University aims to contribute significantly to the global medical community and enhance patient care.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Enas Elgendy, ph.D

Principal Investigator

October 6 University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials